McGill University receives $165 million for genomics and RNA research.

McGill University has been awarded a $165 million grant from the Canada First Research Excellence Fund to launch DNA to RNA (D2R), a global research effort specializing in the development and delivery of more inclusive genomic-based RNA therapeutics. The initiative will receive significant support from over 50 partners, including academic and industry partners, bringing the total amount invested in D2R to $353 million. The team of 70 researchers from five academic institutions will work collaboratively with Canada’s Indigenous and immigrant populations to ensure the promise of RNA therapeutics is made widely available in a manner that is inclusive and beneficial to all Canadians.